Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|November 29, 2023
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directionsDimitrios Nasioudis, Stefan Gysler, Nawar Latif, et al.
JCI Insight|August 21, 2020
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic targetStefano Pierini, Janos L Tanyi, Fiona Simpkins, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2025
Space- and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatraceVictor V Onecha, Daniel Suarez-García, Jesús J Bosque, et al.
Gynecologic Oncology|December 17, 2019
Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data BaseDimitrios Nasioudis, Nawar A Latif, Fiona Simpkins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2023
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgeryDimitrios Nasioudis, Xiaolei Wang, Gurdial Dhillon, et al.
Gynecologic Oncology|September 1, 2023
The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approachesDimitrios Nasioudis, Marta Llaurado Fernandez, Nelson Wong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2026
Results of integrating an automated electronic social determinants of health screening survey in a gynecologic oncology practice: a pilot studyAnna Jo Smith, Caroline Shermoen, Stefanie N Hinkle, et al.
Gynecologic Oncology|April 9, 2011
A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometriumDené C Wrenn, Kunal Saigal, Joseph A Lucci, et al.
Gynecologic Oncology|August 27, 2015
The prescription or proscription of exercise in endometrial cancer careXiaochen Zhang, Ashley F Haggerty, Justin C Brown, et al.
Gynecologic Oncology|April 11, 2017
Cancer-testis antigen expression is shared between epithelial ovarian cancer tumorsArlene E Garcia-Soto, Taylor Schreiber, Natasa Strbo, et al.
Pageof 8